Author, year Country Type of study Cases Controls Type of infections Main results Limits
Evans, 2007 [4] USA Retrospective study Gram negative bacteria, resistant to at least one antibiotic class between aminglicosides, cephalosporins, carbapenems and quinolones Susceptible gram negative bacteria All kind of infection Increase of the length of hospitalisationamong cases compared to controls (29 versus13 days); increase of total hospital cost among cases compared to controls ($80,500 versus$29,604) Single centre; analysis not stratified according to the type of infection and bacterial species.
Lautenbach, 2009 [5] USA Retrospective study Imipenem resistant A. baumannii Imipenem susceptibleA.baumannii All kind of infection No difference of length of hospitalisation and costs between cases and controls Selection bias
Lautenbach, 2010 [6] USA Retrospective study Imipenem resistant P. aeruginosa Imipenem susceptibleP.aeruginosa All kind of infection Increase of the length of hospitalisation among cases compared to controls (16 versus9 days); increase of total hospital cost among cases compared to controls ($251,495 versus$166,196) Selection bias
Lee, 2006 [7] USA Retrospective study ESBL positive E.coli e Klebsiella spp. ESBL negativeE.coli e Klebsiella spp. All kind of infection with the exclusion of urinary tract infections Increase of the length of hospitalisation among cases compared to controls (mean difference 9.7 days, 95% CI 3.2-14.6); increase of mean total hospital cost per patient among cases compared to controls (16,450$, 95% IC $965-31,937) Small sample size; Analysis not adjusted for severity of illness and time at risk; analysis not stratified according to the type of infection and bacterial species
Lee, 2007 [8] Taiwan Retrospective study MDR A.baumannii(resistant to penicillins, cephalosporins, anti-pseudomonas quinolones, aminoglicosides and cotrimoxazole, and sensitive to carbapenems) No MDR A. baumannii Bacteraemia Increase of the length of hospitalisation among cases compared to controls (13.4 days); increase of mean total hospital cost among cases compared to controls ($3,758) Single centre
Mauldin, 2010 [9] USA Retrospective study Gram negative bacteria (Acinetobacterspp, Enterobacterspp, E. coli, Klebsiellaspp, Pseudomonasspp) resistant to at least one class of antibiotics between quinolones, piperacillin, carbapenems or cephalosporins Susceptible gram negative bacteria (Acinetobacterspp, Enterobacterspp, E. coli, Klebsiellaspp, Pseudomonasspp) All kind of infection Increase of the length of hospitalisation among cases compared to controls (23.8%); increase of total hospital cost among cases compared to controls (29.3%) Analysis not adjusted for severity of illness and time at risk; analysis not stratified according to the type of infection and bacterial species
Ng, 2012 [10] Singapore Retrospective study MDR Gram negative bacteria (resistant to at least 3 classes of antibiotics) No MDR gram negative bacteria Bacteraemia increase of total hospital cost among cases compared to controls (45.7%, corresponding to 8,638 Singaporean $ per patient) Analysis not stratified according to the type of infection and bacterial species
Schwaber, 2006 [11] Israel Retrospective study  ESBL positive E.coli, Klebsiellaspp e Proteus spp. ESBL negative E.coli, Klebsiellaspp e Proteus spp Bacteraemia Increase of the length of hospitalisation among cases compared to controls (1.56 fold); increase of total hospital cost among cases compared to controls (1.57 fold corresponding to 13,417 shekels per patient) Single centre
Stewardson, 2013 [12] Switzerland Retrospective study and multi state model ESBL positive Enterobacteriaceae ESBL negative Enterobacteriaceae Bacteraemia Increase of the length of hospitalisation among cases compared to controls (6.8 days); increase of total hospital cost among cases compared to controls (9,473 CHF per patient) Single centre
Tumbarello, 2010 [13] Italy Retrospective study ESBL positive E. coli ESBL negative E. coli Bacteraemia Increase of the length of hospitalisation among cases compared to controls (7 days); increase of total hospital cost per patient among cases compared to controls (EUR 5,026) Single centre
Table 1: Studies on the economic burden of infection by antibiotic-resistant gram-negative bacteria